[HTML][HTML] Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance

AE Tuomisto, MJ Mäkinen… - World journal of …, 2019 - ncbi.nlm.nih.gov
Systemic inflammation is a marker of poor prognosis preoperatively present in around 20%-
40% of colorectal cancer patients. The hallmarks of systemic inflammation include an …

Skin tissue engineering—in vivo and in vitro applications

F Groeber, M Holeiter, M Hampel, S Hinderer… - Advanced drug delivery …, 2011 - Elsevier
Significant progress has been made over the years in the development of in vitro-
engineered substitutes that mimic human skin, either to be used as grafts for the …

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

HF Dvorak - Journal of clinical oncology, 2002 - ascopubs.org
Vascular endothelial growth factor A (VEGF-A), the founding member of the vascular
permeability factor (VPF)/VEGF family of proteins, is an important angiogenic cytokine with …

Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer

R Salgado, S Junius, I Benoy… - … journal of cancer, 2003 - Wiley Online Library
Abstract Interleukin‐6 (IL‐6) is a multifunctional cytokine produced by macrophages, T cells,
B cells, endothelial cells and tumour cells. Interleukin‐6 is able to promote tumour growth by …

Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor

HK Kim, KS Song, YS Park, YH Kang, YJ Lee… - European journal of …, 2003 - Elsevier
The activation of coagulation, angiogenesis and inflammatory cytokines are considered to
be related with tumour growth and metastasis. We investigated the plasma levels of platelet …

Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients

D Santini, B Vincenzi, G Dicuonzo, G Avvisati… - Clinical Cancer …, 2003 - AACR
Purpose: The commercial availability of zoledronic acid, a third generation bisphosphonate,
prompted us to evaluate the modifications in angiogenic cytokines levels after a single iv …

VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients

JE Peterson, D Zurakowski, JE Italiano, LV Michel… - Angiogenesis, 2012 - Springer
Platelets sequester angiogenesis regulatory proteins which suggests an avenue for
developing biomarkers to monitor disease. We describe a comparison of angiogenesis …

Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues

LLY Chiu, M Radisic - Biomaterials, 2010 - Elsevier
The aim of this study was to engineer a biomaterial capable of supporting vascularization in
vitro and in vivo. We covalently immobilized vascular endothelial growth factor (VEGF) and …

Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity

WC Wu, R Lien, PJ Liao, NK Wang, YP Chen… - JAMA …, 2015 - jamanetwork.com
Importance Intravitreous injections of bevacizumab (IVB) have been found to be effective for
the treatment of retinopathy of prematurity (ROP). However, serum levels of vascular …

[HTML][HTML] Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast …

T Bachelot, I Ray-Coquard, C Menetrier-Caux… - British journal of …, 2003 - nature.com
Prediction of survival for patients with metastatic breast cancer is often inaccurate and may
be helped by new biological parameters. Tumour growth being angiogenesis-dependent, it …